Relationship between serum omentin-1 levels and nascent metabolic syndrome in Caucasian patients with obesity
- 1Centro de Investigación en Endocrinología y Nutrición Clínica (IENVA). Facultad de Medicina. Servicio de Endocrinología y Nutrición. Hospital Clínico Universitario. Universidad de Valladolid.
- 0Centro de Investigación en Endocrinología y Nutrición Clínica (IENVA). Facultad de Medicina. Servicio de Endocrinología y Nutrición. Hospital Clínico Universitario. Universidad de Valladolid.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Omentin-1 levels are lower in individuals with metabolic syndrome (MS). Lower omentin-1 correlates with increased adiposity, insulin resistance, and triglycerides, suggesting its role in MS development.
Area Of Science
- Endocrinology
- Metabolic Research
- Obesity Studies
Background
- Metabolic syndrome (MS) is a growing health concern.
- Omentin-1, an adipokine, is implicated in metabolic regulation.
- The relationship between omentin-1 and early-stage MS requires further elucidation.
Purpose Of The Study
- To investigate the association between serum omentin-1 levels and nascent metabolic syndrome in obese subjects.
- To identify predictors of metabolic syndrome in this population.
Main Methods
- A cross-sectional study involving 606 obese individuals.
- Assessment of adiposity, blood pressure, glucose metabolism (including HOMA-IR and TyG index), lipid profile, C-reactive protein, and serum omentin-1.
- Statistical analysis to determine correlations and predictors of MS.
Main Results
- Subjects without MS exhibited significantly higher omentin-1 levels compared to those with MS.
- Omentin-1 showed inverse correlations with adiposity parameters, glucose, insulin, HOMA-IR, TyG index, and triglycerides.
- Omentin-1 demonstrated a positive correlation with HDL-cholesterol.
- Obesity (BMI), insulin resistance (HOMA-IR), and serum omentin-1 were identified as independent predictors of MS.
- A serum omentin-1 cut-off of 372.45 ng/ml was determined for MS prediction.
Conclusions
- Obese Caucasian individuals with nascent MS present with reduced serum omentin-1 levels.
- Serum omentin-1 levels are inversely associated with key metabolic syndrome components, including insulin resistance and triglycerides.
- Omentin-1 may serve as a potential biomarker for early detection of metabolic syndrome in obese populations.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:24
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
01:24
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

